Breaking New Ground
Improving outcomes for people with cancer by translating novel scientific insights into first-in-class immunotherapies
Resilient to Our Core
With grit, expertise and passion, our scientists are enabling transformational shifts in cancer treatment
We’re in this Together
We believe that through dedication and with teams that transcend corporate walls, we can transform patient lives
Recent News
July 21, 2020
Gilead Sciences Secures Exclusive Option to Acquire Tizona Therapeutics for $300 Million
June 25, 2020
Tizona Initiates Clinical Development of TTX-080 in Advanced Cancers
February 19, 2020
Tizona to Present at The Cowen and Company 40th Annual Healthcare Conference